Diener, Hans-Christoph
Day, Kathleen A.
Lipsius, Sarah
Aurora, Sheena K.
Hindiyeh, Nada A.
Detke, Holland C.
Funding for this research was provided by:
Eli Lilly and Company
Article History
Received: 25 July 2024
Accepted: 18 January 2025
First Online: 3 February 2025
Declarations
:
: H-CD received honoraria for contribution to advisory boards or oral presentations from: Lilly, Lundbeck, Novartis, Pfizer and Teva. The German Research Council (DFG) supports his headache research, and serves on the editorial boards of Cephalalgia, Lancet Neurology and Drugs. HCD and KAD are employees of Eli Lilly and Company. N.A.H is a speaker and consultant for Impel, Eli Lilly and Company, and AbbVie. SKA is a former employee of Eli Lilly and is currently employed by C2N diagnostics. SL is an employee of Syneos Health that was contracted by Eli Lilly and Company for this work.